First Trust Nasdaq Pharmaceuticals ETF (FTXH)

Assets	$22.88M
Expense Ratio	0.60%
PE Ratio	15.39
Shares Out	n/a
Dividend (ttm)	$0.42
Dividend Yield	1.61%
Ex-Dividend Date	Sep 22, 2023
Payout Ratio	24.79%
1-Year Return	+4.97%

Volume	660
Open	26.04
Previous Close	25.98
Day's Range	25.81 - 26.04
52-Week Low	23.87
52-Week High	28.59
Beta	n/a
Holdings	51
Inception Date	Sep 20, 2016

About FTXH

Fund Home Page

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is issued by First Trust.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NASDAQ
• Ticker Symbol: FTXH
• Issuer: First Trust
• Index Tracked: Nasdaq US Smart Pharmaceuticals Index

Top 10 Holdings

55.06% of assets

Name	Symbol	Weight
AbbVie Inc.	ABBV	7.72%
Johnson & Johnson	JNJ	7.39%
Merck & Co., Inc.	MRK	7.24%
Bristol-Myers Squibb Company	BMY	7.08%
Pfizer Inc.	PFE	6.86%
Amgen Inc.	AMGN	3.88%
Cardinal Health, Inc.	CAH	3.77%
Vertex Pharmaceuticals Incorporated	VRTX	3.76%
Regeneron Pharmaceuticals, Inc.	REGN	3.68%
Eli Lilly and Company	LLY	3.67%

Dividends

Ex-Dividend	Amount	Pay Date
2023-09-22	$0.0725	2023-09-29
2023-06-27	$0.1179	2023-06-30
2023-03-24	$0.1001	2023-03-31
2022-12-23	$0.1253	2022-12-30
2022-09-23	$0.0911	2022-09-30
2022-06-24	$0.0384	2022-06-30